keyword
https://read.qxmd.com/read/38649735/cannabidiol-an-effective-analgesic-for-toothache
#1
JOURNAL ARTICLE
Siofra Murphy, Ellis Hayes
DESIGN: This study is a randomised, placebo-controlled, triple-arm, phase IIA clinical trial with double masking which investigates the effectiveness and safety of Cannabidiol (CBD) as an analgesic for acute dental pain. The intervention drug, Epidiolex is an FDA-approved CBD oral solution (100 mg/ml) derived from the cannabis plant. The psychoactive ingredient tetrahydrocannabinol (THC) is not included. The maximum recommended daily dose of Epidiolex is 20 mg/kg. 64 patients with moderate-severe odontogenic pain participated in the study and REDCap software was utilised to randomly assign participants into groups: CBD10 (10 mg/kg), CBD20 (20 mg/kg) and placebo...
April 22, 2024: Evidence-based Dentistry
https://read.qxmd.com/read/38649680/hexahydrocannabinol-hhc-and-%C3%AE-9-tetrahydrocannabinol-%C3%AE-9-thc-driven-activation-of-cannabinoid-receptor-1-results-in-biased-intracellular-signaling
#2
JOURNAL ARTICLE
Oleh Durydivka, Petr Palivec, Matej Gazdarica, Ken Mackie, Jaroslav Blahos, Martin Kuchar
The Cannabis sativa plant has been used for centuries as a recreational drug and more recently in the treatment of patients with neurological or psychiatric disorders. In many instances, treatment goals include relief from posttraumatic disorders, anxiety, or to support treatment of chronic pain. Ligands acting on cannabinoid receptor 1 (CB1R) are also potential targets for the treatment of other health conditions. Using an evidence-based approach, pharmacological investigation of CB1R agonists is timely, with the aim to provide chronically ill patients relief using well-defined and characterized compounds from cannabis...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38648838/adolescent-cannabis-use-and-suicidality
#3
JOURNAL ARTICLE
Katherine Bergs, Christina Nicole Davis, Silvio D Martinez, John Stillson, Madelaine Wade
No abstract text is available yet for this article.
April 2024: American Family Physician
https://read.qxmd.com/read/38645644/full-spectrum-cannabidiol-rich-extract-reduced-propofol-dosage-required-for-anesthetic-induction-in-dogs-a-pilot-study
#4
JOURNAL ARTICLE
João Lourenço Hasckel Gewehr, Maria Laura Enzele, Lucas Marlon Freiria, Morgana Martins Nunes, Júlia Spengler, Ana Paula Dondoerfer Teixeira, Erik Amazonas, Vanessa Sasso Padilha
INTRODUCTION: Cannabinoids show great therapeutic potential, but their effect on anesthesia still remains unclear. Use of chronic recreational Cannabis in humans undergoing anesthetic procedures tends to require a higher dose when compared to non-users. On the other hand, studies on rodents and dogs have shown that cannabinoid agonists may potentiate certain anesthetics. This contrast of effects possibly occurs due to different time lengths of administration of different phytocannabinoids at different doses, and their distinct effects on the Endocannabinoid System, which is also affected by anesthetics such as propofol and isoflurane...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38641178/medicinal-cannabis-oil-improves-anxiety-like-and-depressive-like-behaviors-in-ccs-mice-via-the-bdnf-trpc6-signaling-pathway
#5
JOURNAL ARTICLE
Baoying Shen, Zhixing Wang, Huijing Yu, Xin Shen, Lin Li, Yi Ru, Chunqi Yang, Guangxu Du, Chengcai Lai, Yue Gao
BACKGROUND: Post-traumatic stress disorder (PTSD) refers to a chronic impairing psychiatric disorder occurring after exposure to the severe traumatic event. Studies have demonstrated that medicinal cannabis oil plays an important role in neuroprotection, but the mechanism by which it exerts anti-PTSD effects remains unclear. METHODS: The chronic complex stress (CCS) simulating the conditions of long voyage stress for 4 weeks was used to establish the PTSD mice model...
April 17, 2024: Behavioural Brain Research
https://read.qxmd.com/read/38640173/morphological-and-clinical-findings-in-placentas-and-newborns-with-a-history-of-tobacco-alcohol-and-other-substance-abuse-during-pregnancy
#6
JOURNAL ARTICLE
H F Mendez-Reyes, M Franco-Olaya, O Canon-Cubillos, J M Uribe-Lopez, M C Delgado-Alvarez, M Velasquez-Portilla, M Olaya-C
BACKGROUND: Exposure to toxins during pregnancy is the main modifiable behavior that affects the placenta and, consequently, the fetus. In particular, smoking is a recognized risk factor for negative outcomes. Our study pretended to examine gross and microscopic placental features in women who reported exposure to tobacco, alcohol, or other psychoactive substances. METHODS: In this observational case-control study, we collected 706 placentas to assess precise substance exposure histological-interaction features of in the placenta...
April 13, 2024: Journal of Neonatal-perinatal Medicine
https://read.qxmd.com/read/38639578/medicinal-cannabis-in-neurodegenerative-disorders-an-open-label-dose-finding-safety-and-efficacy-study
#7
JOURNAL ARTICLE
Peter K Panegyres, Kerry L Lind, Cheryl A MacFarlane, Allana L Gurney
Aim: Currently, there exist no curative treatments for neurodegenerative disorders. Recently, there has been a resurgence of interest in the use of medicinal cannabis to improve neurological conditions. Methods: A 12-month, open label, dose-finding, safety and efficacy study was conducted including 48 subjects with a variety of neurodegenerative disorders. Results: In our participants, we observed a reduction in pain, improved sleep, enhanced well-being and less agitation. Conclusion: Our findings suggest that medicinal cannabis might be useful in patients with neurodegenerative disorders in controlling pain, enhancing sleep, reducing difficult behaviors, controlling unusual and complex symptoms when other treatments have failed - this offers medicinal cannabis a role in palliation...
April 19, 2024: Neurodegenerative Disease Management
https://read.qxmd.com/read/38639006/mendelian-randomization-causal-inference-leveraging-genetic-data
#8
REVIEW
Lane G Chen, Justin D Tubbs, Zipeng Liu, Thuan-Quoc Thach, Pak C Sham
Mendelian randomization (MR) leverages genetic information to examine the causal relationship between phenotypes allowing for the presence of unmeasured confounders. MR has been widely applied to unresolved questions in epidemiology, making use of summary statistics from genome-wide association studies on an increasing number of human traits. However, an understanding of essential concepts is necessary for the appropriate application and interpretation of MR. This review aims to provide a non-technical overview of MR and demonstrate its relevance to psychiatric research...
April 19, 2024: Psychological Medicine
https://read.qxmd.com/read/38635412/cannabis-effectiveness-on-immunologic-potency-of-pulmonary-contagion
#9
REVIEW
Sumana Das, Arya Ghosh, Varnita Karmakar, Sourav Khawas, Piyush Vatsha, Kishor Kumar Roy, Padma Charan Behera
Respiratory illnesses and its repercussions are becoming more prevalent worldwide. It is necessary to research both innovative treatment and preventative techniques. Millions of confirmed cases and fatalities from the COVID-19 epidemic occurred over the previous two years. According to the review research, cannabinoids are a class of medicines that should be considered for the treatment of respiratory conditions. Cannabinoids and inhibitors of endocannabinoid degradation have illustrated advantageous anti-inflammatory, asthma, pulmonary fibrosis, and pulmonary artery hypotension in numerous studies ( in vitro and in vivo )...
April 19, 2024: Journal of Basic and Clinical Physiology and Pharmacology
https://read.qxmd.com/read/38632206/genome-wide-view-and-characterization-of-natural-antisense-transcripts-in-cannabis-sativa-l
#10
JOURNAL ARTICLE
Chang Zhang, Mei Jiang, Jingting Liu, Bin Wu, Chang Liu
Natural Antisense Transcripts (NATs) are a kind of complex regulatory RNAs that play crucial roles in gene expression and regulation. However, the NATs in Cannabis Sativa L., a widely economic and medicinal plant rich in cannabinoids remain unknown. In this study, we comprehensively predicted C. sativa NATs genome-wide using strand-specific RNA sequencing (ssRNA-Seq) data, and validated the expression profiles by strand-specific quantitative reverse transcription PCR (ssRT-qPCR). Consequently, a total of 307 NATs were predicted in C...
April 17, 2024: Plant Molecular Biology
https://read.qxmd.com/read/38630896/-the-wild-west-of-medicine-a-qualitative-investigation-of-the-factors-influencing-australian-health-care-practitioners-delivery-of-medicinal-cannabis
#11
JOURNAL ARTICLE
Olivia Dobson, Michaela Barber, Myfanwy Graham, Adrian Carter, Michael Savic
INTRODUCTION: Strong patient interest in the use of medicinal cannabis to treat various clinical indications has sparked global legislative changes. Practitioners are vital in implementing regulatory changes and facilitating patient access to medicinal cannabis, however, little is currently known about the factors influencing practitioners' uptake. Recent rapid increases in practitioner applications to prescribe medicinal cannabis in Australia provides a unique backdrop to examine the current factors influencing prescribing behaviours...
April 17, 2024: Drug and Alcohol Review
https://read.qxmd.com/read/38625758/a-flowering-locus-t-ortholog-is-associated-with-photoperiod-insensitive-flowering-in-hemp-cannabis-sativa-l
#12
JOURNAL ARTICLE
Caroline A Dowling, Jiaqi Shi, Jacob A Toth, Michael A Quade, Lawrence B Smart, Paul F McCabe, Susanne Schilling, Rainer Melzer
Hemp (Cannabis sativa L.) is an extraordinarily versatile crop, with applications ranging from medicinal compounds to seed oil and fibre products. Cannabis sativa is a short-day plant, and its flowering is highly controlled by photoperiod. However, substantial genetic variation exists for photoperiod sensitivity in C. sativa, and photoperiod-insensitive ("autoflower") cultivars are available. Using a bi-parental mapping population and bulked segregant analysis, we identified Autoflower2, a 0.5 Mbp locus significantly associated with photoperiod-insensitive flowering in hemp...
April 16, 2024: Plant Journal
https://read.qxmd.com/read/38619849/recreational-cannabis-legalization-retail-sales-and-adolescent-substance-use-through-2021
#13
JOURNAL ARTICLE
Rebekah Levine Coley, Naoka Carey, Claudia Kruzik, Summer Sherburne Hawkins, Christopher F Baum
No abstract text is available yet for this article.
April 15, 2024: JAMA Pediatrics
https://read.qxmd.com/read/38619169/point-of-care-ultrasound-for-the-diagnosis-of-an-atypical-small-bowel-obstruction-in-a-cannabis-user-a-case-report
#14
JOURNAL ARTICLE
Alaa Beshir, Jonas Bruyns, Maximilien Thoma, Florence Dupriez
This case report describes an atypical small bowel obstruction in a 71- years old cannabis user and how point-of-care of ultrasound (PoCUS) helped to its management by further orientating the physician toward the bowel obstruction etiology, namely intussusception. Intussusception is the invagination of an intestinal segment into the adjacent segment. The acute clinical presentation of intussusception often has non-specific symptoms, and the diagnosis can be challenging. While the most common etiology is neoplasm, intussusception also occurs in bowel motility disorder such as after cannabis use...
2024: Acute Medicine
https://read.qxmd.com/read/38612793/water-extracts-from-industrial-hemp-waste-inhibit-the-adhesion-and-development-of-candida-biofilm-and-showed-antioxidant-activity-on-ht-29-colon-cancer-cells
#15
JOURNAL ARTICLE
Leonardo Donati, Debora Casagrande Pierantoni, Angela Conti, Eleonora Calzoni, Laura Corte, Claudio Santi, Ornelio Rosati, Gianluigi Cardinali, Carla Emiliani
The evolution of regulatory perspectives regarding the health and nutritional properties of industrial hemp-based products ( Cannabis sativa L.) has pushed research to focus on the development of new methods for both the extraction and formulation of the bioactive compounds present in hemp extracts. While the psychoactive and medicinal properties of hemp-derived cannabinoid extracts are well known, much less has been investigated on the functional and antimicrobial properties of hemp extracts. Within the hemp value chain, various agricultural wastes and by-products are generated...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611577/in-pursuit-of-optimal-quality-cultivar-specific-drying-approaches-for-medicinal-cannabis
#16
JOURNAL ARTICLE
Matan Birenboim, Nimrod Brikenstein, Danielle Duanis-Assaf, Dalia Maurer, Daniel Chalupowicz, David Kenigsbuch, Jakob A Shimshoni
A limited number of studies have examined how drying conditions affect the cannabinoid and terpene content in cannabis inflorescences. In the present study, we evaluated the potential of controlled atmosphere drying chambers for drying medicinal cannabis inflorescence. Controlled atmosphere drying chambers were found to reduce the drying and curing time by at least 60% compared to traditional drying methods, while preserving the volatile terpene content. On the other hand, inflorescences subjected to traditional drying were highly infested by Alternaria alternata and also revealed low infestation of Botrytis cinerea ...
April 8, 2024: Plants (Basel, Switzerland)
https://read.qxmd.com/read/38611521/improved-long-term-preservation-of-cannabis-inflorescence-by-utilizing-integrated-pre-harvest-hexanoic-acid-treatment-and-optimal-post-harvest-storage-conditions
#17
JOURNAL ARTICLE
Matan Birenboim, Daniel Chalupowicz, David Kenigsbuch, Jakob A Shimshoni
The effort to maintain cannabinoid and terpene levels in harvested medicinal cannabis inflorescence is crucial, as many studies demonstrated a significant concentration decrease in these compounds during the drying, curing, and storage steps. These stages are critical for the preparation and preservation of medicinal cannabis for end-use, and any decline in cannabinoid and terpene content could potentially reduce the therapeutic efficacy of the product. Consequently, in the present study, we determined the efficacy of pre-harvest hexanoic acid treatment alongside four months of post-harvest vacuum storage in prolonging the shelf life of high THCA cannabis inflorescence...
March 30, 2024: Plants (Basel, Switzerland)
https://read.qxmd.com/read/38611090/review-of-the-use-of-medicinal-cannabis-products-in-palliative-care
#18
REVIEW
James Troyer, Kimberson Tanco
In this review, we discuss the potential role of cannabis and cannabinoids in the management of cancer-related symptoms. There is limited evidence demonstrating the effectiveness of cannabis-based products in treating cancer-related pain and gastrointestinal symptoms such as nausea, vomiting, and loss of appetite. Regarding the role of cannabis-based products in the treatment of insomnia and mood disorders, most studies looked at these symptoms as secondary outcomes with mixed results. Cannabis-based products have adverse effects, ranging from neuropsychiatric to systemic effects to potential drug interactions...
April 4, 2024: Cancers
https://read.qxmd.com/read/38609178/exposure-to-in-utero-cannabis-is-linked-to-a-higher-risk-of-low-birthweight-prematurity-and-admission-to-a-neonatal-unit
#19
JOURNAL ARTICLE
J Petty
No abstract text is available yet for this article.
April 12, 2024: Evidence-based Nursing
https://read.qxmd.com/read/38608233/preliminary-results-from-a-phase-iv-surveillance-study-of-medical-cannabis-use-in-australian-patients-with-advanced-cancer-receiving-palliative-care
#20
JOURNAL ARTICLE
Taylan Gurgenci, Janet Hardy, Christopher Good, Phillip Good
Introduction: Our research group is conducting three large randomized placebo-controlled trials of medicinal cannabis for cancer symptoms. All participants are invited to take part in a posttrial surveillance study. Methods: Participants were given the manufacturers dosing instructions and liberty to titrate to effect. Data were collected on symptoms (Edmonton Symptom Assessment Scale [ESAS] score), perceived benefits, adverse effects, satisfaction with the product, and dose/frequency. Results: Twenty-six percent of eligible participants consented to take part in the surveillance study...
April 12, 2024: Journal of Palliative Medicine
keyword
keyword
87697
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.